1. Market Research
  2. > Pharmaceutical Market Trends
  3. > China Chinese Prepared Medicines Market Report

China Chinese Prepared Medicines Market Report

  • July 2013
  • -
  • Beijing Zeefer Consulting Ltd
  • -
  • 51 pages

This report presents a clear picture about the overall development of Chinese prepared medicines market in China and the trend in recent years based on detailed data analysis. This report includes the analysis on the Chinese prepared medicines market size and market share in China, the study on major hot areas in this market, introduction of key data and the comparison of major 10 enterprises in terms of sales revenue and market share, the detailed description of the import and export…

This report covers following sections.

- Market Size
Based on Zeefer's China Market Size Formula, by the analysis on market size, industry sales revenue and domestic output in 2009-2012, this report presents a picture of the real development of China market and changes in the overall market size.

- Hot Areas
Based on the comparison and analysis on production volume and import in different provinces or cities, this report points out those hot areas in this market deserve most attention.

- Major 10 Enterprises
Based on the comparison and analysis on major 10 leading enterprises in terms of sales revenue, market share and number of employees, the report shows their market positions in China. Additionally, this report lists basic contact information of the major 10 leading enterprises.

- Market Share and Market Structure
This report analyzes the market share distribution by segments based on enterprises nature (leading enterprises, foreign enterprises, state-owned and private enterprises), imports and regional markets in China in terms of sale revenue, profitability, production volume, number of enterprises and the value of imports... The report offers data on the market shares of imported products, foreign enterprises and enterprises in other forms. It also offers a comparison of profitability by forms of enterprise ownership, presents a picture of the market share of leading enterprises and the distribution of major regional markets in China. In addition, the report figures out the structure and concentration ratio of the current Chinese prepared medicines market in China by means of Bain's Market Structure Classification and Index of CR4.

- Import and Export
In this section, the report includes the main source countries / regions of imported products for China and their market shares, the domestic destinations of imported products in China and shares for these destinations, major export destinations (countries or regions) for Chinese products and shares of these destinations, major origins of the exported products and their shares.

- Industry Standards
The report lists relevant national standards and/or industrial standards concerning Chinese prepared medicines products generally accepted in China, including standard names both in Chinese and English as well as their unified code numbers.

- Major Importers
The report lists 10 major importers for Chinese prepared medicines products in China and provides their contact information such as company name, address, website, telephone number and fax number.

- Key Statistics
Based on the concise analysis on the sales revenue, production volume, number of enterprises, total profit, total loss, total assets, return on the asset and profit margin as well as other key statistics, the report presents the current situation, the growth rate and profitability of this industry in China.

* Product definition
Chinese prepared medicines products mentioned in this report is a general concept, it shall include the following products:
Classified by the United Nation's Central Product Classification (CPC)
CPC Code: 35260
Based on the United Nation's Central Product Classification (CPC Version 1.1), Chinese prepared medicines refer to medicaments, for therapeutic or prophylactic uses.

Table Of Contents

China Chinese Prepared Medicines Market Report
Chapter 1 Product Definition 1
Chapter 2 Market Size 3
2.1 Analysis On The Chinese Prepared Medicines Market Size 3
2.2 Analysis On The Changes In Chinese Prepared Medicines Production Volume In Recent Years 5
2.3 An Overview On Chinese Economy 6
Chapter 3 Hot Spots For Chinese Prepared Medicines Products Across China 10
Chapter 4 Industry Overview 12
4.1 A Summary On The Industry 12
4.2 An Analysis On The Profitability Of The Industry 13
Chapter 5 Analysis On Import and Export 16
5.1 An Overview On The Import and Export 16
5.2 A Detailed Analysis On Import and Export Of Chinese Prepared Medicines Products 18
5.2.1 Analysis On Major Countries Of Origin For The Imported Chinese Prepared Medicines Products 18
5.2.2 Analysis On The Major Flow Destinations Inside China 20
5.2.3 Analysis On Major Export Destinations 21
5.2.4 Analysis On Major Origins In China 22
Chapter 6 The Market Share 24
6.1 Analysis On The Concentration Of Corporate Sales Revenue 24
6.1.1 Analysis On The Concentration Of Sales Revenue From Leading Enterprises 24
6.1.2 Comparative Analysis On Sales Revenue From Major 10 Enterprises With Industry Average 26
6.2 Analysis On The Concentration By Area In Terms Of The Market Share 28
6.2.1 Analysis On Concentration Of Regional Sales Revenue 28
6.2.2 Analysis On The Concentration Of Regional Production Volume 29
6.3 Market Position Of Foreign Enterprises And The Trend In Recent Years 31
6.3.1 Changes In The Shares Of Foreign Enterprises In Terms Of The Numbers And The Comparison Of Foreign Enterprises And Enterprises Of Other Ownership 31
6.3.2 Changes In The Shares Of Sales Revenue From Foreign Enterprises And Comparison With That From Enterprises Of Other Ownership 33
6.3.3 Profitability Of Foreign Enterprises And Comparison With Enterprises Of Other Ownership 35
6.4 Analysis On The Market Share Of Imported Products And Relevant Variations In Recent Years 37
Chapter 7 Major 10 Enterprises 39
7.1 Xiuzheng Pharmaceutical Group Co., Ltd. 39
7.2 Tianjin Zhongxin Pharmaceutical Group Co., Ltd. 39
7.3 Huiren Group Co., Ltd. 40
7.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. 41
7.5 Taiji Group Chongqing Fuling Pharmaceutical Factory Co., Ltd. 41
7.6 Yunnan Baiyao Group Co., Ltd. (Wuhua) 42
7.7 Shandong Dong E E Jiao Co., Ltd. 42
7.8 Huazhi Holding (Zhejiang) Co., Ltd. 43
7.9 Henan Wanxi Pharmaceutical Co., Ltd. 43
7.10 Shineway Pharmaceutical Co., Ltd. 44
Chapter 8 Product Standard Systems 45
Chapter 9 List Of Major Importers 46

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.